Federal contract award
75A50124C00048
NYTRICX, INC. R&D FOR PREVENTION OF ECMO CIRCUIT THROMBOSIS AND INFECTION BY SURFACE RELEASE OF NITRIC OXIDE (NO) AOI #19
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AN15 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPENSES FOR R&D FACILITIES AND MAJOR EQUIPMENT |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $746.0K |
| Current contract value | $746.0K |
| Potential contract value / ceiling | $746.0K |
| Start date | Sep 3, 2024 |
| Current end date | Jun 9, 2026 |
| Potential end date | Jun 9, 2026 |
| Latest award activity | Sep 12, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 12, 2025 | P00003 | $0 | NYTRICX, INC. R&D FOR PREVENTION OF ECMO CIRCUIT THROMBOSIS AND INFECTION BY SURFACE RELEASE OF NITRIC OXIDE (NO) AOI #19 |
| May 6, 2025 | P00002 | $0 | NYTRICX, INC. R&D FOR PREVENTION OF ECMO CIRCUIT THROMBOSIS AND INFECTION BY SURFACE RELEASE OF NITRIC OXIDE (NO) AOI #19 |
| Dec 16, 2024 | P00001 | $0 | NYTRICX, INC. R&D FOR PREVENTION OF ECMO CIRCUIT THROMBOSIS AND INFECTION BY SURFACE RELEASE OF NITRIC OXIDE (NO) AOI #19 |
| Sep 13, 2024 | 0 | $746.0K | NYTRICX, INC. R&D FOR PREVENTION OF ECMO CIRCUIT THROMBOSIS AND INFECTION BY SURFACE RELEASE OF NITRIC OXIDE (NO) AOI #19 |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.